Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,625 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessment for the timing of comprehensive genomic profiling tests in patients with advanced solid cancers.
Hagio K, Kikuchi J, Takada K, Tanabe H, Sugiyama M, Ohhara Y, Amano T, Yuki S, Komatsu Y, Osawa T, Hatanaka KC, Hatanaka Y, Mitamura T, Yabe I, Matsuno Y, Manabe A, Sakurai A, Ishiguro A, Takahashi M, Yokouchi H, Naruse H, Mizukami Y, Dosaka-Akita H, Kinoshita I. Hagio K, et al. Among authors: takada k. Cancer Sci. 2023 Aug;114(8):3385-3395. doi: 10.1111/cas.15837. Epub 2023 May 19. Cancer Sci. 2023. PMID: 37208840 Free PMC article.
Clinical significance of comprehensive genomic profiling tests covered by public insurance in patients with advanced solid cancers in Hokkaido, Japan.
Kikuchi J, Ohhara Y, Takada K, Tanabe H, Hatanaka K, Amano T, C Hatanaka K, Hatanaka Y, Mitamura T, Kato M, Shibata Y, Yabe I, Endoh A, Komatsu Y, Matsuno Y, Sugiyama M, Manabe A, Sakurai A, Takahashi M, Naruse H, Torimoto Y, Dosaka-Akita H, Kinoshita I. Kikuchi J, et al. Among authors: takada k. Jpn J Clin Oncol. 2021 Apr 30;51(5):753-761. doi: 10.1093/jjco/hyaa277. Jpn J Clin Oncol. 2021. PMID: 33532831
Effect of comprehensive cancer genomic profiling on therapeutic strategies and clinical outcomes in patients with advanced biliary tract cancer: A prospective multicenter study.
Takada K, Kubo T, Kikuchi J, Yoshida M, Murota A, Arihara Y, Nakamura H, Nagashima H, Tanabe H, Sugita S, Tanaka Y, Miura A, Ohhara Y, Ishiguro A, Yokouchi H, Kawamoto Y, Mizukami Y, Ohnishi H, Kinoshita I, Sakurai A. Takada K, et al. Front Oncol. 2022 Sep 2;12:988527. doi: 10.3389/fonc.2022.988527. eCollection 2022. Front Oncol. 2022. PMID: 36119486 Free PMC article.
Clinical characterization of patients with gBRCA1/2 mutation-positive unresectable pancreatic cancer: a multicenter prospective study.
Kubo T, Muramatsu J, Arihara Y, Murota A, Ishikawa K, Yoshida M, Nagashima H, Tamura F, Ikeda Y, Usami M, Ono M, Nakamura H, Watanabe D, Shibata T, Kasahara K, Sakurai A, Takada K. Kubo T, et al. Among authors: takada k. Jpn J Clin Oncol. 2024 Jan 7;54(1):47-53. doi: 10.1093/jjco/hyad131. Jpn J Clin Oncol. 2024. PMID: 37791389 Free PMC article.
Case series of three patients with hereditary diffuse gastric cancer in a single family: Three case reports and review of literature.
Hirakawa M, Takada K, Sato M, Fujita C, Hayasaka N, Nobuoka T, Sugita S, Ishikawa A, Mizukami M, Ohnuma H, Murase K, Miyanishi K, Kobune M, Takemasa I, Hasegawa T, Sakurai A, Kato J. Hirakawa M, et al. Among authors: takada k. World J Gastroenterol. 2020 Nov 14;26(42):6689-6697. doi: 10.3748/wjg.v26.i42.6689. World J Gastroenterol. 2020. PMID: 33268956 Free PMC article. Review.
2,625 results